Treatment of Salmonellosis with Saccharomyces boulardii
نویسندگان
چکیده
منابع مشابه
Saccharomyces cerevisiae var. boulardii fungemia following probiotic treatment
Probiotics are commonly prescribed as an adjuvant in the treatment of antibiotic-associated diarrhea caused by Clostridium difficile. We report the case of an immunocompromised 73-year-old patient on chemotherapy who developed Saccharomyces cerevisiae var. boulardii fungemia in a central venous catheter during treatment of antibiotic-associated pseudomembranous colitis with the probiotic Saccha...
متن کاملMetabolic Engineering of Probiotic Saccharomyces boulardii.
Saccharomyces boulardiiis a probiotic yeast that has been used for promoting gut health as well as preventing diarrheal diseases. This yeast not only exhibits beneficial phenotypes for gut health but also can stay longer in the gut than Saccharomyces cerevisiae Therefore, S. boulardiiis an attractive host for metabolic engineering to produce biomolecules of interest in the gut. However, the lac...
متن کاملSaccharomyces Boulardii - a Probiotic of Choice
The term ―probiotic‖ was first used in 1965 by Lilly and Stillwell, to describe substances secreted by one organism which stimulate the growth of another probiotics as ―live micro-organisms‖, which, when administered in adequate amounts confer a health benefit on the host .The use of probiotics for the prevention of antibiotic associated diarrhea (AAD) and the treatment of Clostridium difficile...
متن کاملTreatment of recurrent Clostridium difficile colitis with vancomycin and Saccharomyces boulardii.
Recurrence of Clostridium difficile-associated diarrhea and pseudomembranous colitis occurs in up to 20% of patients after standard therapy. In these patients, subsequent recurrences are even more frequent. Saccharomyces boulardii, a nonpathogenic yeast, was found to be effective in preventing clindamycin cecitis recurrence in an animal model. We performed an open trial of S. boulardii to evalu...
متن کاملTreatment of diarrhea-predominant irritable bowel syndrome with mesalazine and/or Saccharomyces boulardii.
CONTEXT Irritable bowel syndrome (IBS) is a functional bowel disease characterized by abdominal pain and altered intestinal habits. The pathophysiology of IBS remains unclear. Recent studies have demonstrated that some IBS patients, especially in diarrhea-predominant IBS (IBS-D), display persistent signs of minor mucosal inflammation and a modified intestinal microflora. The mesalazine has know...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: International Journal of Infectious Diseases
سال: 2008
ISSN: 1201-9712
DOI: 10.1016/j.ijid.2008.05.513